| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |